{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:05:28Z","timestamp":1790046328644,"version":"4.0.1"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Drug resistance remains the first and most significant barrier to long-term curative benefits in lung cancer patients. Traditional resistance mechanisms focused on oncogenic driver mutations are inadequate to explain reversible tumor phenotypic plasticity under therapeutic stress. Increasing evidence has placed mitochondrial metabolic rewiring as the core signaling hub bridging energy homeostasis to nuclear epigenetic reprogramming; however, a comparative review of this metabolic-transcriptional axis in lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and small cell lung cancer (SCLC) remains underrepresented. Here, this review integrates the published preclinical and translational data, dissecting how mitochondrial dysfunction, including altered oxidative phosphorylation (OXPHOS), TCA metabolite accumulation, ROS imbalance, and defective mitochondrial quality control, establishesdrug-tolerant persister (DTP) states. Subsequently, we elaborate on the conserved and subtype-specific genetic and epigenetic cascades induced by mtDNA variants, oncogenes (MYC\/RAS), tumor suppressors (p53\/LKB1), and oncometabolites (\u03b1-ketoglutarate, succinate, fumarate) that remodel chromatin landscapes and further initiate lineage plasticity, epithelial-mesenchymal transition, and immune evasion. We summarize promising mitochondrial-targeted interventions from OXPHOS inhibitors, fatty acid oxidation blockers, ROS modulators, and epigenetic agents and propose combinatorial therapeutic regimens according to the three lung cancer subtypes. This work establishes a unified metabolic-resilience framework and highlights multi-omics integrated profiling as a new paradigm in precision medicine to forecast resistance risk and reverse therapeutic failure in lung cancer.<\/jats:p>","DOI":"10.3389\/fgene.2026.1958851","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:56:31Z","timestamp":1790045791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial metabolic-transcriptional axis drives adaptive drug tolerance across major lung cancer subtypes"],"prefix":"10.3389","volume":"17","author":[{"given":"Ruixuan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zetong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Respiratory, Affiliated Huishan Hospital of Xinglin College, Nantong University, Wuxi Huishan District People\u2019s Hospital","place":["Wuxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical School of Nantong University","place":["Nantong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1101\/2025.09.19.677388","volume-title":"Dietary \u03b1-Ketoglutarate Delays Lung Adenocarcinoma in Females and Modulates TBX5-associated Transcriptional Programs and the Immune Microenvironment","author":"Alcaraz","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21128","DOI":"10.1038\/s41598-020-77284-8","article-title":"Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of notch, hedgehog, wnt, and ErbB signalling","volume":"10","author":"Anusewicz","year":"2020","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1038\/s41388-025-03502-0","article-title":"RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer","volume":"44","author":"Cao","year":"2025","journal-title":"Oncogene"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7621","DOI":"10.1038\/s41467-025-62911-7","article-title":"Respiration defects limit serine synthesis required for lung cancer growth and survival","volume":"16","author":"Cararo Lopes","year":"2025","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1158\/1078-0432.CCR-18-4140","article-title":"MYC-driven small-cell lung cancer is metabolically distinct and vulnerable to arginine depletion","volume":"25","author":"Chalishazar","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/s41467-019-10042-1","article-title":"Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","article-title":"Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer","volume":"23","author":"Davidson","year":"2016","journal-title":"Cell Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1158\/1078-0432.CCR-15-0375","article-title":"Reversal of warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non\u2013small cell lung cancer","volume":"21","author":"De Rosa","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.7150\/thno.123679","article-title":"Targeting CPS1 attenuates lung cancer metastasis by regulating EMT through an epigenetic mechanism","volume":"16","author":"Ding","year":"2026","journal-title":"Theranostics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e187448","DOI":"10.1172\/jci.insight.187448","article-title":"Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis","volume":"10","author":"Du","year":"","journal-title":"JCI Insight"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.pharmr.2025.100076","article-title":"Cracking the EGFR code: cancer biology, resistance mechanisms, and future therapeutic frontiers","volume":"77","author":"Du","year":"","journal-title":"Pharmacol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41556-023-01210-z","article-title":"KDM6A epigenetically regulates subtype plasticity in small cell lung cancer","volume":"25","author":"Duplaquet","year":"2023","journal-title":"Nat. Cell Biology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.apsb.2022.10.023","article-title":"Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-Mutant lung cancer","volume":"13","author":"Feng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0154576","DOI":"10.1371\/journal.pone.0154576","article-title":"Cancer stem cells in small cell lung cancer cell line H446: higher dependency on oxidative phosphorylation and mitochondrial substrate-level phosphorylation than non-stem cancer cells","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1101\/2025.08.06.668958","volume-title":"HDAC Inhibition Unlocks Tumor Plasticity and Enhances Immunotherapy Response in Myc-Driven Small Cell Lung Cancer","author":"Ghafoor","year":"2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1101\/gad.340133.120","article-title":"MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity","volume":"34","author":"Grunblatt","year":"2020","journal-title":"Genes and Dev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41556-018-0261-6","article-title":"Akt methylation by SETDB1 promotes Akt kinase activity and oncogenic functions","volume":"21","author":"Guo","year":"2019","journal-title":"Nat. Cell Biology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/ncomms4261","article-title":"Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma","volume":"5","author":"Han","year":"2014","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12931-021-01655-6","article-title":"Chronic intermittent hypoxia promoted lung cancer stem cell-like properties via enhancing Bach1 expression","volume":"22","author":"Hao","year":"2021","journal-title":"Respir. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1021\/acs.jmedchem.2c01844","article-title":"Discovery of a potent and oral available complex I OXPHOS inhibitor that abrogates tumor growth and circumvents MEKi resistance","volume":"66","author":"He","year":"2023","journal-title":"J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1158\/1078-0432.ccr-22-1128","article-title":"Inhibition of LSD1 with bomedemstat sensitizes small cell lung cancer to immune checkpoint blockade and T cell killing","volume":"28","author":"Hiatt","year":"2022","journal-title":"Clin. Cancer Research An Official Journal Am. Assoc. Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/1878-0261.13808","article-title":"Respiratory complex I-mediated NAD(+) regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21(Cip1) expression by SIRT3 and SIRT7","volume":"19","author":"Higurashi","year":"2025","journal-title":"Mol. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","article-title":"Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway","volume":"19","author":"Holze","year":"2018","journal-title":"Nat. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-025-08355-9","article-title":"Non-canonical NOTCH1 signaling regulates ferroptosis vulnerability in dormant lung cancer cells with stable resistance","volume":"17","author":"Huang","year":"2025","journal-title":"Cell Death Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-16-0127","article-title":"Role of KEAP1\/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiotherapy response prediction","volume":"7","author":"Jeong","year":"2016","journal-title":"Cancer Discovery"},{"key":"B29","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","article-title":"Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma?","volume":"1807","author":"Jose","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13578-018-0257-8","article-title":"Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis","volume":"8","author":"Kalainayakan","year":"2018","journal-title":"Cell and Biosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"110133","DOI":"10.18632\/oncotarget.22655","article-title":"Acquired resistance to PI3K\/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis","volume":"8","author":"Koh","year":"2017","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nature13198","article-title":"Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity","volume":"508","author":"Kraus","year":"2014","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12929-022-00878-z","article-title":"Cancer-derived extracellular succinate: a driver of cancer metastasis","volume":"29","author":"Kuo","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ccell.2015.04.001","article-title":"LKB1 inactivation elicits a redox imbalance to modulate non-small cell lung cancer plasticity and therapeutic response","volume":"27","author":"Li","year":"2015","journal-title":"Cancer Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/0008-5472.CAN-22-2370","article-title":"PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2024.10.017","article-title":"Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1","volume":"37","author":"Lin","year":"2025","journal-title":"Cell Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","article-title":"The complexity of p53-mediated metabolic regulation in tumor suppression","volume":"85","author":"Liu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B39","article-title":"Chromatin remodeling induced by ARID1A loss in lung cancer promotes glycolysis and confers JQ1 vulnerability","author":"Liu","year":"2022","journal-title":"Cancer Research"},{"key":"B40","volume-title":"PIK3CA Mutation as an Acquired Resistance Driver to EGFR-TKIs in Non-small Cell Lung Cancer: Clinical Challenges and Opportunities","author":"Liu","year":"2025"},{"key":"B41","article-title":"PARP inhibition induces synthetic lethality and adaptive immunity in LKB1-mutant lung cancer","author":"Long","year":"2022","journal-title":"Cancer Research"},{"key":"B42","doi-asserted-by":"publisher","first-page":"21156","DOI":"10.1021\/acsnano.4c04024","article-title":"Mitochondria-Targeted multifunctional nanoprodrugs by inhibiting metabolic reprogramming for combating cisplatin-resistant lung cancer","volume":"18","author":"Lu","year":"2024","journal-title":"ACS Nano"},{"key":"B43","doi-asserted-by":"publisher","first-page":"102006","DOI":"10.1016\/j.redox.2021.102006","article-title":"Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and fatty acid biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence","volume":"43","author":"Luis","year":"2021","journal-title":"Redox Biol."},{"key":"B44","volume-title":"Mitochondrial TCA Cycle Metabolites Control Physiology and Disease","author":"Mart\u00edNEZ-Reyes","year":"2025"},{"key":"B45","article-title":"Single cell analysis reveals transcriptomic features of drug tolerant persisters and stromal adaptation in a patient-derived EGFR-Mutated lung adenocarcinoma xenograft model","author":"Moghal","year":"2022","journal-title":"J. Thoracic Oncology Official Publication Int. Assoc. Study Lung Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41586-019-1715-0","article-title":"In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer","volume":"575","author":"Momcilovic","year":"2019","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s43018-022-00361-6","article-title":"KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming","volume":"3","author":"Na","year":"2022","journal-title":"Nat. Cancer"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-LB446","article-title":"Abstract LB446: development of drug candidate for metastatic cancer by targeting pathogenic mitochondrial DNA","author":"Nagase","year":"2025","journal-title":"Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.isci.2018.04.013","article-title":"Mitochondria-targeted honokiol confers a striking inhibitory effect on lung cancer via inhibiting complex I activity","volume":"3","author":"Pan","year":"2018","journal-title":"iScience"},{"key":"B50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-022-01547-3","article-title":"Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR\/Src\/Erk\/SP1 signaling-mediated ERR\u03b1 re-expression","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"B51","doi-asserted-by":"crossref","first-page":"1539808","DOI":"10.3389\/fimmu.2025.1539808","article-title":"Bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction","volume":"16","author":"Pan","year":"2025","journal-title":"Front. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13046-021-02049-8","article-title":"Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting","volume":"40","author":"Parma","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1039\/d5na00094g","article-title":"Hydroxycitrate-loaded exosomes demonstrate enhanced therapeutic efficacy against lung adenocarcinoma by inhibiting the metabolic enzyme ATP citrate lyase","volume":"7","author":"Phutela","year":"2025","journal-title":"Nanoscale Adv."},{"key":"B54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.32604\/or.2022.026302","article-title":"The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models","volume":"30","author":"Qian","year":"2022","journal-title":"Oncol. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1096\/fj.11-196543","article-title":"Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer","volume":"26","author":"Rehman","year":"2012","journal-title":"FASEB Journal"},{"key":"B56","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"B57","doi-asserted-by":"publisher","first-page":"114282","DOI":"10.1016\/j.bcp.2020.114282","article-title":"Therapeutic potential of targeting mitochondrial dynamics in cancer","volume":"182","author":"Rodrigues","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/mc.23603","article-title":"Mitochondria-targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species","volume":"62","author":"Shameem","year":"2023","journal-title":"Mol. Carcinog."},{"key":"B60","volume-title":"Spatiotemporal Control of Acetyl-CoA Metabolism in Chromatin Regulation","author":"Sivanand","year":"2025"},{"key":"B61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neo.2019.10.006","article-title":"Targeting histone deacetylase SIRT1 selectively eradicates EGFR TKI-Resistant cancer stem cells via regulation of mitochondrial oxidative phosphorylation in lung adenocarcinoma","volume":"22","author":"Sun","year":"2019","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"B62","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1136\/gutjnl-2020-320652","article-title":"RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer","volume":"70","author":"Sun","year":"2021","journal-title":"Gut"},{"key":"B63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/cancers12010068","article-title":"TCA cycle rewiring as emerging metabolic signature of hepatocellular carcinoma","volume":"12","author":"Todisco","year":"2019","journal-title":"Cancers"},{"key":"B64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41389-022-00400-y","article-title":"Analysis of the metabolic proteome of lung adenocarcinomas by reverse-phase protein arrays (RPPA) emphasizes mitochondria as targets for therapy","volume":"11","author":"Torresano","year":"2022","journal-title":"Oncogenesis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/ol.2022.13627","article-title":"Fumarate hydratase inhibits non-small cell lung cancer metastasis via inactivation of AMPK and upregulation of DAB2","volume":"25","author":"Vadhan","year":"2023","journal-title":"Oncol. Lett."},{"key":"B66","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mrrev.2015.01.001","article-title":"How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models","volume":"764","author":"Van Gisbergen","year":"2015","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/1541-7786.mcr-20-1006","article-title":"Sox2 is an oncogenic driver of small-cell lung cancer and promotes the classic neuroendocrine subtype","volume":"19","author":"Voigt","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1111\/bph.17460","article-title":"Sculponeatin A induces mitochondrial dysfunction in non-small cell lung cancer through WWP2-mediated degradation of mitochondrial STAT3","volume":"182","author":"Wan","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12951-021-00895-4","article-title":"pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer","volume":"19","author":"Wang","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41419-023-05678-3","article-title":"TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2\/PI3K\/AKT\/OPA1 axis","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"227","DOI":"10.7150\/jca.92797","article-title":"Demethylzeylasteral inhibits oxidative phosphorylation complex biogenesis by targeting LRPPRC in lung cancer","volume":"16","author":"Wang","year":"","journal-title":"J. Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/0008-5472.can-24-2054","article-title":"Mutation of SMARCA4 induces cancer cell\u2013intrinsic defects in the enhancer landscape and resistance to immunotherapy","volume":"85","author":"Wang","year":"","journal-title":"Cancer Res."},{"key":"B73","volume-title":"Inhibition of \u03b1-KG-dependent Histone and DNA Demethylases by Fumarate and Succinate that are Accumulated in Mutations of FH and SDH Tumor Suppressors","author":"Xiao","year":"2025"},{"key":"B74","doi-asserted-by":"publisher","first-page":"682762","DOI":"10.3389\/fonc.2021.682762","article-title":"SIRT1\/PGC-1\u03b1\/PPAR-\u03b3 correlate with hypoxia-induced chemoresistance in non-small cell lung cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e20240111","DOI":"10.1084\/jem.20240111","article-title":"TET2\u2013STAT3\u2013CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition","volume":"221","author":"Xue","year":"2024","journal-title":"J. Exp. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/biomedicines11051490","article-title":"DCLK1 drives EGFR-TKI-Acquired resistance in lung adenocarcinoma by remodeling the epithelial\u2013mesenchymal transition status","volume":"11","author":"Yan","year":"2023","journal-title":"Biomedicines"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/2159-8290.CD-17-0987","article-title":"Intertumoral heterogeneity in SCLC is influenced by the cell type of origin","volume":"8","author":"Yang","year":"2018","journal-title":"Cancer Discov."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the genetic regulation of cancer metabolism: interplay between glycolysis and oxidative phosphorylation","volume":"77","author":"Yu","year":"2017","journal-title":"Cancer Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3724\/abbs.2023247","article-title":"p32\/OPA1 axis-mediated mitochondrial dynamics contributes to cisplatin resistance in non-small cell lung cancer","volume":"56","author":"Yu","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"eabg6428","DOI":"10.1126\/scitranslmed.abg6428","article-title":"Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"B81","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jtho.2022.11.019","article-title":"Pten loss expands the histopathological diversity and lineage plasticity of lung cancers initiated by Rb1\/Trp53 deletion","volume":"18","author":"Zhang","year":"","journal-title":"J. Thoracic Oncology Official Publication Int. Assoc. Study Lung Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3390\/cancers14102538","article-title":"Chemoprevention of lung cancer with a combination of mitochondria-targeted compounds","volume":"14","author":"Zhang","year":"","journal-title":"Cancers (Basel)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"eade4113","DOI":"10.1126\/scitranslmed.ade4113","article-title":"Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway","volume":"15","author":"Zhang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1420643","DOI":"10.3389\/fphar.2024.1420643","article-title":"Insights into the role of mitophagy in lung cancer: current evidence and perspectives","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"B85","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-025-01722-w","article-title":"A ROS-Mediated oxidation-O-GlcNAcylation cascade governs ferroptosis","author":"Zhang","year":""},{"key":"B86","doi-asserted-by":"crossref","first-page":"e06950","DOI":"10.1002\/advs.202506950","article-title":"EGFR-TKIs induced DPP4 drives metabolic reprogramming of persister cells in lung cancer","volume":"12","author":"Zhang","year":"","journal-title":"Adv. Sci. (Weinh)"},{"key":"B87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jare.2024.04.030","article-title":"Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression","volume":"70","author":"Zhao","year":"2025","journal-title":"J. Adv. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e918216","DOI":"10.12659\/msm.918216","article-title":"Altered mitochondrial dynamics, biogenesis, and functions in the paclitaxel-resistant lung adenocarcinoma cell line A549\/taxol","volume":"26","author":"Zhou","year":"2020","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"B89","article-title":"Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma","author":"Zhou","year":"2025","journal-title":"A Retrospective Analysis Comparing Clinical Characteristics Outcomes Response Systematic Treatments"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1039\/c8sc04871a","article-title":"Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism","volume":"10","author":"Zhu","year":"2019","journal-title":"Chem. Sci."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1958851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:56:36Z","timestamp":1790045796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1958851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":86,"alternative-id":["10.3389\/fgene.2026.1958851"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1958851","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1958851"}}